BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35430273)

  • 1. MAFB promotes the malignant phenotypes by IGFBP6 in esophageal squamous cell carcinomas.
    Zhang S; Gong T; Nan Y; Feng R; Liu Z; Chen H
    Exp Cell Res; 2022 Jul; 416(1):113158. PubMed ID: 35430273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.
    Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ
    J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
    Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
    Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LHX2 Enhances the Malignant Phenotype of Esophageal Squamous Cell Carcinoma by Upregulating the Expression of SERPINE2.
    Li X; Wu X; Chen H; Liu Z; He H; Wang L
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F1-activated NRSN2 promotes esophageal squamous cell carcinoma progression through AKT/mTOR pathway.
    Yan Z; Xu T; Lu J; Wu Z; Li X; Xu J; Guo W; Dong Z
    Pathol Res Pract; 2022 Aug; 236():153963. PubMed ID: 35662041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-11 activated by lnc-ATB promotes cell proliferation and invasion in esophageal squamous cell cancer.
    Yang SM; Li SY; Hao-Bin Y; Lin-Yan X; Sheng X
    Biomed Pharmacother; 2019 Jun; 114():108835. PubMed ID: 30954889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PURα mediates epithelial-mesenchymal transition to promote esophageal squamous cell carcinoma progression by regulating Snail2.
    Gao J; Tian L; Sun Y; Li W; Zhao L; Sun Y; Jing Z; Zhou L; Liu F; Zhao X
    Cancer Lett; 2021 Feb; 498():98-110. PubMed ID: 33144099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NEFL promotes invasion and migration of esophageal squamous carcinoma cells via the EGFR/AKT/S6 pathway.
    Fan ZL; Yang LY; Zhang N; Feng D; Guo J; Chang C; Yuan Q; Cai Y; Zhang Y; Wei WQ; Wang MR; Hao JJ
    Yi Chuan; 2022 Apr; 44(4):322-334. PubMed ID: 35437240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-2 mRNA-binding protein 3 promotes cell migration, invasion, and epithelial-mesenchymal transition of esophageal squamous cell carcinoma cells by targeting zinc finger E-box-binding homeobox 1 mRNA.
    Feng Y; Lin Y; Jiang Z; Wu L; Zhang Y; Wu H; Yuan X
    Mol Carcinog; 2023 Apr; 62(4):503-516. PubMed ID: 36688673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Assays of Biological Aggressiveness of Esophageal Squamous Cell Carcinoma.
    Islam F; Gopalan V; Lam AK
    Methods Mol Biol; 2020; 2129():161-175. PubMed ID: 32056177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA GK-IT1 promotes esophageal squamous cell carcinoma by regulating MAPK1 phosphorylation.
    Yang X; Zeng T; Liu Z; He W; Hu M; Tang T; Chen L; Xing L
    Cancer Med; 2022 Dec; 11(23):4555-4574. PubMed ID: 35608100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis.
    Feng YF; Lei YY; Lu JB; Xi SY; Zhang Y; Huang QT; Wu QL; Wang F
    Cell Death Dis; 2018 Oct; 9(11):1085. PubMed ID: 30348939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
    Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X
    Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
    Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
    J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
    Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
    Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
    Wu D; He X; Wang W; Hu X; Wang K; Wang M
    Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP18 promotes tumor metastasis in esophageal squamous cell carcinomas via deubiquitinating ZEB1.
    Song C; Peng J; Wei Y; Shao J; Chen X; Zhang X; Xu J
    Exp Cell Res; 2021 Dec; 409(1):112884. PubMed ID: 34743935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ETV5 overexpression promotes progression of esophageal squamous cell carcinoma by upregulating SKA1 and TRPV2.
    Sun MC; Fang K; Li ZX; Chu Y; Xu AP; Zhao ZY; Leng ZY; Zhang YW; Zhang ZH; Zhang L; Chen T; Xu MD
    Int J Med Sci; 2022; 19(6):1072-1081. PubMed ID: 35813298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA‑200a promotes esophageal squamous cell carcinoma cell proliferation, migration and invasion through extensive target genes.
    Yang B; Liu Y; Li L; Deng H; Xian L
    Mol Med Rep; 2020 May; 21(5):2073-2084. PubMed ID: 32323771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcription factor c-Jun regulates Smad4 expression by upregulating pre-miR-183 expression to promote invasion and metastasis of esophageal squamous cell carcinomas.
    Xu X; Zheng L; Hang N; Zhu G; Mao W; Fan Y; Tao K
    In Vitro Cell Dev Biol Anim; 2020 Aug; 56(7):550-558. PubMed ID: 32886291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.